Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Inflammatory Bowel Diseases

Free Subscription 26.05.2025 2 Aliment Pharmacol Ther 2 BMC Gastroenterol 3 Clin Gastroenterol Hepatol 1 Dig Dis 3 Dig Dis Sci 1 Dis Colon Rectum 4 Gastroenterol Hepatol 2 Inflamm Bowel Dis 8 J Crohns Colitis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. BARBERIO B, Gracie DJ, Black CJ, Ford AC, et al
   Network Meta-Analysis: Efficacy of Biological Therapies and Small Molecules as Maintenance Therapy in Ulcerative Colitis.
   Aliment Pharmacol Ther. 2025 May 23. doi: 10.1111/apt.70209.
   PubMed         Abstract available
   
   
2. OSTY M, Altwegg R, Serrero M, Benezech A, et al
   Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
   Aliment Pharmacol Ther. 2025 May 22. doi: 10.1111/apt.70199.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. MENDIOLAZA M, Vicioso C, Siddiqui W, Lingineni K, et al
   Initial development and validation of a disease-specific resilience measure for inflammatory bowel disease: the RISE-IBD instrument.
   BMC Gastroenterol. 2025;25:390.
   PubMed         Abstract available
   
   
4. MOE OK, Gao Q, Geng D, Jensen E, et al
   Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study.
   BMC Gastroenterol. 2025;25:389.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. COHEN NA, Sror N, Naseer M, Bettenworth D, et al
   DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEW.
   Clin Gastroenterol Hepatol. 2025 May 14:S1542-3565(25)00416.
   PubMed         Abstract available
   
   
6. BACCARELLA A, Patel T, Conrad MA, Macchi M, et al
   Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease.
   Clin Gastroenterol Hepatol. 2025 May 14:S1542-3565(25)00404.
   PubMed         Abstract available
   
   
7. KANG B, Kim ES, Choi S, Choe BH, et al
   Proactive Drug Monitoring versus Clinically-based Dosing for Endoscopic Healing in Pediatric Crohn's Disease Receiving Infliximab.
   Clin Gastroenterol Hepatol. 2025 May 14:S1542-3565(25)00412.
   PubMed         Abstract available
   
   

   
   Dig Dis

8. SARBAGILI-SHABAT C, Zelber-Sagi S, Fliss Isakov N, Hirsch A, et al
   High ultra-processed food consumption is associated with clinical exacerbation in patients with Crohn's disease in remission - a prospective cohort study.
   Dig Dis. 2025 May 20:1-17. doi: 10.1159/000546486.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

9. OBAIDULLAH Z, Hassan MB, Fatima M, Kumar A, et al
   Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
   Dig Dis Sci. 2025 May 22. doi: 10.1007/s10620-025-09104.
   PubMed        
   
   
10. O'DONNELL JEM, Leach ST, Bowcock NL, Chen S, et al
    Correction: Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.
    Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09061.
    PubMed        
    
    
11. FEAGINS LA, Reveles KR
    Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?
    Dig Dis Sci. 2025 May 17. doi: 10.1007/s10620-025-09088.
    PubMed        
    
    

    
    Dis Colon Rectum

12. ZIEGLER O, Soderman CJ, Greene AC, Deutsch MJ, et al
    Twenty Years of Disease Modifying Anti-Inflammatory Bowel Disease Drug Use Preceding Colectomy for Refractory Inflammatory Bowel Disease-Associated Colitis.
    Dis Colon Rectum. 2025 May 20. doi: 10.1097/DCR.0000000000003826.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

13. GIORDANO A, Baston I, Madero L, Brunet-Mas E, et al
    Unraveling the Gut-Fat-Inflammation Connection in Crohn's Disease: A Path to New Therapeutic Targets?
    Gastroenterol Hepatol. 2025 May 14:502466. doi: 10.1016/j.gastrohep.2025.502466.
    PubMed        
    
    
14. GISBERT JP, Chaparro M
    Etrasimod: Review of the efficacy and therapeutic prospects of a new oral therapy for the treatment of ulcerative colitis.
    Gastroenterol Hepatol. 2025;48:502363.
    PubMed         Abstract available
    
    
15. ROBLES-ALONSO V, Solans R, Lastiri E, Serra X, et al
    Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.
    Gastroenterol Hepatol. 2025;48:502258.
    PubMed         Abstract available
    
    
16. CORREAL EN, Gomez DM, Sequeiros AR, Gonzalo FM, et al
    Insights into the status of the quality of nursing care in patients with inflammatory bowel disease: A nationwide survey (The MAPEA Project).
    Gastroenterol Hepatol. 2025 May 14:502464. doi: 10.1016/j.gastrohep.2025.502464.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

17. SUN J, Brooks EC, Houshyar Y, Connor SJ, et al
    Unravelling the Relationship Between Obesity and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 May 21:izaf098. doi: 10.1093.
    PubMed         Abstract available
    
    
18. ISHIDA N, Tamura S, Takebe T, Takahashi K, et al
    Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional Study.
    Inflamm Bowel Dis. 2025 May 21:izaf025. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

19. POULSEN A, Alexdottir MS, Riis LB, Ovesen PD, et al
    Serum Biomarkers of Collagen Remodeling are Associated with Intestinal Fibrosis and Differentiates Stenotic from Luminal Crohn's Disease Patients: A Pre- and Post-Resection Longitudinal Study.
    J Crohns Colitis. 2025 May 20:jjaf085. doi: 10.1093.
    PubMed         Abstract available
    
    
20. ARTONE S, Ray S, Williams JJ, Akbulut K, et al
    The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.
    J Crohns Colitis. 2025 May 20:jjaf083. doi: 10.1093.
    PubMed         Abstract available
    
    
21. OU W, Wang Y, Xu W, Hua Z, et al
    Restoring Prostacyclin/PGI2-PTGIR Signaling Alleviates Intestinal Fibrosis in Crohn's Disease via Fibroblast-specific YAP/TAZ Inhibition.
    J Crohns Colitis. 2025 May 20:jjaf084. doi: 10.1093.
    PubMed         Abstract available
    
    
22. 
    Correction to: Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
    J Crohns Colitis. 2025;19:jjaf077.
    PubMed        
    
    
23. BOURGONJE AR, Ibing S, Livanos AE, Ganjian DY, et al
    Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease.
    J Crohns Colitis. 2025 May 18:jjaf082. doi: 10.1093.
    PubMed         Abstract available
    
    
24. GEYL S, Jacques J, Anneraud A, Chaussade S, et al
    Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED.
    J Crohns Colitis. 2025;19:jjaf057.
    PubMed         Abstract available
    
    
25. VERSTOCKT S, Sabino J, Ferrante M, Vermeire S, et al
    Serum extracellular RNAs as a noninvasive approach to differentiate inflammatory bowel disease subtypes: a proof-of-concept study.
    J Crohns Colitis. 2025;19:jjaf047.
    PubMed         Abstract available
    
    
26. DUBINSKY MC, Wu J, McDonnell A, Lazin K, et al
    Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development Program.
    J Crohns Colitis. 2025;19:jjae173.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.